These findings suggest that COX-2 and its metabolic products can play a critical role in the production and aggregation of Aβ in the brain, and may contribute to the development and progression of Alzheimer's disease (Guan et al., 2019, Xiang et al., 2002). This evidence concerns the gene PTGS2 and Alzheimer disease.